On Friday, Tango Therapeutics Inc (TNGX) stock saw a decline, ending the day at $3.85 which represents a decrease of $-0.07 or -1.79% from the prior close of $3.92. The stock opened at $3.95 and ...

Investment analysts at B. Riley upped their FY2024 earnings estimates for Tango Therapeutics in a research note issued to ...

In recent trading, Tango Therapeutics Inc (TNGX) stock price has shown some volatility, fluctuating 38.52% over the last five trades and -45.10% over the past 30 trades. This represents a notable ...

Tango Therapeutics (NASDAQ:TNGX – Get Free Report) had its price target cut by investment analysts at B. Riley from $16.00 to ...

Tango Therapeutics (TNGX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Robert ...

Tango Therapeutics, Inc. (TNGX) came out with a quarterly loss of $0.27 per share versus the Zacks Consensus Estimate of a loss of $0.34. This compares to loss of $0.23 per share a year ago. These ...

Barclays analyst Peter Lawson maintained a Buy rating on Tango Therapeutics (TNGX – Research Report) today and set a price target of ...

Strong cash position of $293 million as of September 30, 2024, with cash runway into 3Q 2026 to prioritize resourcing of ...

Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the ...

View Tango Therapeutics, Inc. (TNGX) current and estimated P/E ratio data provided by Seeking Alpha.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...